Introduction
Heart rate variability biofeedback (HRVB) has enjoyed a good deal of popularity in recent years. A number of commercial products have been introduced ranging in price from $80 (MyCalmBeat by Brain Resourcet) to over $200 (Alivee by Somatic Vision, Inc.). The advertising for these products claims efficacy for a large number of disorders and, in fact, we are quite optimistic about the potential for these techniques, especially when combined with mindfulness-based interventions (Khazan, 2013) . In this article, I will review the state of the empirical literature for the use of HRVB with and without other clinical components. Wheat and Larkin (2010) reviewed some of the HRVB literature and concluded that ''Results revealed that HRV biofeedback consistently effectuates acute improvements during biofeedback practice, whereas the presence of short-term and long-term carry-over effects is less clear' ' (p. 229) . A substantial number of studies have appeared since that review.
As developed in the early 1980s, HRVB was conceived as an intervention that would target the parasympathetic nervous system (PNS) in contrast to other peripheral techniques that focused the sympathetic nervous system (SNS) or muscles (see Lehrer, this issue for a history). We now think of the training as affecting cardiovascular homeostatic reflexes so as to increase flexibility and recovery from fight/flight adaptive situations. In addition, we are now investigating the vagal afferent pathways that may explain some of the central effects described below (MacKinnon, Gevirtz, McCraty, & Brown, 2013) . A third pathway has been described by Tracey (2002) and involves the cholinergic or parasympathetic systems regulating the inflammatory response. The following review is organized by these possible mechanisms of action. Much more research will be necessary to elucidate these and other mechanisms, but the trend to organize treatments by mechanistic pathways has become useful in many areas of science.
Possible Mechanism I: Restoring Autonomic Homeostasis
The primary proposed mechanistic path for HRVB has been the restoration of autonomic balance or homeostasis as a product of the training. Thus, disorders such as asthma, functional gastrointestinal disorders (FGID), cardiovascular disorders, fibromyalgia (FM), hypertension, and chronic muscle pain seem to respond to HRVB in a manner that suggests improved autonomic regulation. Table 1 lists the studies that fall into these categories.
Asthma and Chronic Obstructive Pulmonary Disorder (COPD) HRVB has been shown to be a powerful intervention for asthma. Lehrer and his colleagues (2004) have published a well-designed, comprehensive study in which HRVB with home practice was compared to three other credible treatments. The HRVB participants reported fewer symptoms, had better lung function, with no medication boosts (Lehrer, Smetankin, & Potapova, 2000; Lehrer et al., 2004) . Dr. Lehrer's team is currently evaluating HRVB in a multisite, NIH-funded random control trial. One member of the original team (Giardino, Chan, & Borson, 2004 ) headed a group evaluating functional improvements in COPD. 
Functional Gastrointestinal Disorders
In recent years (Gershon, 1998) , a great deal of progress has been made in understanding the enteric nervous system and its autonomic regulation. There now exists an institute in London devoted to neurogastroenterology (Wingate Institute, Barts University). This group has shown that esophageal pain thresholds are dramatically affected by sixper-minute breathing maneuvers (Botha, Naqvi, Chua, Knowles, & Aziz, 2012) . For these reasons, it seems likely that the HRVB techniques may be working through the autonomic regulation pathway. A number of outcome studies are listed, most of which report very large effect sizes. One study coming out of our research group (Sowder, Gevirtz, Shapiro, & Ebert, 2010) showed that improvement was mediated by the restoration of vagal tone presumably influenced by the HRVB. A recent study from the U.K. compared hypnosis to HRVB for irritable bowel syndrome. Both groups showed nice improvements with the HRVB group reporting slightly more reduction in symptoms (though the difference was not quite significant). The HRVB group improved by six standard deviations. This application appears to be one of the most promising for the HRVB.
Fibromyalgia (FM)
The vast literature on FM does include some references to HRVB (Hassett & Gevirtz, 2009; Hassett et al., 2007) , though it appears that a more integrated approach is necessary that includes exercise, therapies such as acceptance and commitment therapy (ACT) or cognitivebehavioral therapy (CBT), exercise (Jones & Liptan, 2009) , and sleep hygiene. The leading rheumatologists in the field do urge integrated treatment and often include biofeedback among the components (Benett, 2013; Hassett & Gevirtz, 2009) Cardiac Rehabilitation As Table 1 shows, there is a promising literature using HRVB for various cardiologic disorders. Within cardiology, it is increasingly recognized that balancing SNS and PNS activity is a crucial component of cardiac health (Sabbah, 2011; Sabbah et al., 2011) . The work at the Cleveland Clinic led by Chris Moravec is especially exciting in that it shows the potential impact of HRVB on the heart muscle itself (Moravec & McKee, 2013) .
Hypertension
The use of biofeedback in treating essential hypertension is well known within the field. However, results using finger temperature or electromyography (EMG) feedback have been limited (Linden & Moseley, 2006) . Here we see HRVB as a potential modality that might work more efficiently by strengthening the baroreflex. More research is needed to determine the strength of the baroreflex as a mediator. Both Reinke, Gevirtz, and Mussgay (2007) and Vaschillo, Lehrer, Rishe, and Konstantinov (2002) have shown substantial gains in baroreflex sensitivity with HRVB training).
Chronic Muscle Pain
As shown in Table 1 , a few studies have shown the efficacy of using HRVB with chronic pain syndromes. Our group has demonstrated that ''trigger points'' (TPs) are sympathetically mediated (Gevirtz, 2006; Hubbard, 1996 Hubbard, , 1998 Hubbard & Berkoff, 1993) . A recent study (Vagades et al., 2011) carried out in Germany has shown that adding HRVB to traditional back exercises and trigger point release produced the greatest pain relief in back pain patients. The mechanism hypothesized to be in play for TPs is known as ''accentuated antagonism'' (Olshansky, Sabbah, Hauptman, & Colucci, 2008; Schwegler & Jacob, 1975; Yang & Levy, 1984) . It has been shown that good autonomic balance allows the PNS to govern the SNS in nonemergency situations. Therefore, the use of HRVB may be effective by blocking some of the sympathetic overflow to TPs.
Obstetric/Gynecological Conditions
As can be seen in Table 1 , a few studies have recently appeared that seem to show promise for conditions such as pregnancy-induced hypertension and preterm labor. In our recent study, which we hope to replicate soon, the HRVB group had almost two weeks added gestation period with significantly heavier babies (Cullin et al., in press ).
Possible Mechanism II: Central Effects by Way of the Vagal Afferent Nerve
A second proposed mechanism grows out of the work on vagal nerve stimulation and deep brain stimulation (Ching et al., 2012; Christopher et al., 2012; Garcia-Navarrete et al., 2012; George et al., 1994; George et al., 2000; Hauptman & Mathern, 2012; Holtzheimer et al., 2012; Lozano et al., 2012; Mayberg, 2003) . The fact that a pacemaker or electrical stimulation can sometimes reverse intractable depression or epilepsy leads to attempts to see whether HRVB, which promotes slow diaphragmatic breathing, and which in turn stimulates subdiaphragmatic vagal afferents (Porges, 2011) , can have central effects. Whether or not this is the primary mechanism, it appears that HRVB is a promising intervention for depression, anxiety, sleep, and possibly optimal performance. I include optimal performance in this grouping because several groups have used neurofeedback as well with mixed results. For all of these disorders, factors such as cognition, mindfulness, and self-efficacy changes are likely a part of the picture.
Further evidence for these central effects comes from heart period evoked potential (HEP) studies that show that Heart Rate Variability Biofeedback Heart Rate Variability Biofeedback factors such as interoception, heartbeat detection, or slow breathing affect the brain (Fukushima, Terasawa, & Umeda, 2011; MacKinnon et al., 2013; Terhaar, Viola, Bar, & Debener, 2003) .
Depression
As can be seen in Table 2 , there have been a number of studies showing decreased depression levels with HRVB. In fact, we have found this to be a common result even in studies where the depression is secondary to trauma or anxiety. We have just completed another study comparing HRVB to EMG biofeedback, which showed reduced depression in a sample that only had mild levels of depression. This has been a somewhat unexpected finding, but one that bears future research, especially with the recent reports of the equivalence of SSRIs and placebo (Fournier et al., 2010; Kirsch et al., 2008; Turner, Matthews, Linardatos, Tell, & Rosenthal, 2008) . Combining HRVB with other empirically based therapies will also contribute to our understanding of depression mechanisms.
Anxiety
Fewer studies have been reported for anxiety, though a lot of anecdotal evidence is out there on the stress reducing effects of HRVB. Devices like the StressErasert or the emWavet, and now the MyCalmBeat and Inner Balancet, are testimonies to the perception of the antistress properties of HRVB. As can be seen in Table 2 , there are some data to support this. An area of future interest is the use of HRVB for trauma symptoms. We are currently investigating adding HRVB to therapies such as prolonged exposure, cognitive processing, or ACT. The argument for this approach is laid out by van der Kolk (2001 Kolk ( , 2006 . Much more research is needed, especially given the escalating incidence of trauma symptoms reactive to military and civilian experiences of trauma.
Sleep
Sleep is an area that seems likely to respond to HRVB, but little has been reported as yet. The one study published that looked at lab-induced insomnia is a promising start (Ebben, Kurbatov, & Pollak, 2009 ).
Optimal Performance
Performance in sports and the arts is a potentially fruitful application. Vaschillo and colleagues (2002) first reported their results in the USSR in the early days of HRVB (see Lehrer, 2013, this issue) . At professional meetings, we have seen a number of exciting anecdotal reports with golfers, gymnasts, baseball hitters, dancers, and musicians. Unfortunately, only a few studies with adequate controls have been reported.
Possible Mechanism III: The Cholinergic Anti-Inflammatory System
Kevin Tracey and others have investigated regulation of an inflammatory response mediated by the PNS (Tracey, 2002; Tracey, Alexander, Eyre, & Singh, 1985) . These researchers suggest that PNS interventions might be able to modulate inflammatory responses that are not functional and that might create problems such as autoimmune disease or poor healing. Thus far only one study has attempted to investigate this with HRVB (Lehrer et al., 2010) . The results were impressive in that HRVB reduced cytokine symptoms compared to controls, but did not affect the interleukins themselves. This may prove to be an important application, but it is still in its infancy.
Conclusion
In summary, a number of research studies have given at least tentative support for the effectiveness for a wide range of medical and emotional disorders. Each cluster of disorders discussed here shows a probable psychophysiological pathway of action, by means of which heart rate variability biofeedback is likely to ameliorate the production of symptoms. Additional research is needed to further demonstrate the efficacy of HRVB in each cluster of disorders, and to solidify current understandings of the likely mechanisms of action.
